Habakkuk is proud to announce a new partnership. Habakkuk will take over as the Central Oklahoma MedShape distributor.
MedShape, Inc. is a privately held orthopedic device company located in Atlanta, GA working to provide innovative surgical solutions to foot and ankle surgeons using a patented NiTiNOL and shape memory polymer technologies. Revolutionizing the way we treat ankle fusions, the DynaNail® TTC Fusion System is designed for use in tibiotalocalcaneal (TTC) fusion procedures to address degenerative conditions, correct joint deformities and revise failed total ankle replacements or arthrodesis non-unions.
Since partnering with Heraeus Medical, the inventor and exclusive manufacturer of PALACOS®, several elite institutions such as OU Medical Center, McBride Orthopedic Hospital and Community Hospital of HPI, have taken advantage of Habakkuk’s limited-time PALACOS® discount.
These prestigious medical facilities are committed to being pacesetters within the industry by providing exceptional products to their patients in order to maintain the highest levels of excellence. Holding distinctions such as Blue Distinction Center+, Oklahoma’s only Level One Trauma center as verified by the American College of Surgeons and the Guardian of Excellence award, these facilities will have the opportunity to impact hundreds of patients with the PALACOS® product.
As PALACOS® moves closer to celebrating sixty years as the gold standard in joint fixation, Habakkuk is excited to provide Oklahoma customers with this discount through a direct purchasing relationship, ensuring immediate and seamless access to the PALACOS® portfolio of high-quality cements and mixing systems.
Habakkuk is excited to bring the best bone cement in the world at its best price yet.
Click here for more information about how you can get your PALACOS® discount.
Habakkuk employees recently attended the Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS) in Dallas, TX. The AAHKS annual meeting addresses a broad array of scientific topics such as implant design, outcomes, surgical techniques and complications of primary and revision total joint arthroplasty (TJA) for hip and knee surgeons.
One of the company’s core values is to deliver exceptional product and performance. Habakkuk demonstrates this commitment to excellence through education and innovation, both of which are provided through events like AAHKS.
Josh Rich, Habakkuk Orthopedic Sales Representative said, “AAKHS was an incredible experience and a great opportunity to be exposed to innovative and exceptional products. I’m excited to utilize this knowledge to better serve the orthopedic community of Oklahoma.”
Habakkuk champion, Dr. Corey Ponder, orthopedic surgeon at St. Anthony’s Bone and Joint Hospital, recently completed his 2,222 OMNIBotics® robotic-assisted total knee replacement surgery on Sept. 25. The first orthopedic surgeon in Oklahoma to utilize OMNIBotics® technology, Dr. Ponder’s milestone contributes to OMNIlife science™, Inc.’s 17,000 total procedures.
The OMNIBotics® technology allows Dr. Ponder a variety of advantages including intraoperative flexibility, ultra-fine precision, patient specific planning and confirmation of proposed corrections. The patient, suffering from severe pain and difficulty standing and walking, benefitted greatly from the total knee replacement.
“The advanced technology of OMNIBotics® provides me the tool to perform knee replacements with patient-specific accuracy and precision. The platform allows for maximal efficiency and flexibility to restore joint alignment and kinematics and achieve successful surgical outcomes. Combined with the industry leading service and wisdom provided by the team at Habakkuk, the future of robotically-assisted joint replacement is more promising than ever,” says Dr. Ponder.
OMNIlife Science™ Inc. explains that the OMNIBotics’® system enables optimized implant placement using robotics driven by OMNI’s proprietary ART™ software. This equipment gives surgeons the ability to efficiently plan a specific procedure for each individual patient using a patented intra-operative 3-D modeling technique that no longer requires preoperative CT scans or x-rays. Therefore, resulting in a more precise alignment of the knee implant that many surgeons believe can lead to more rapid recovery and a more natural feeling knee replacement.
Habakkuk’s Founder and CEO, Clay Steves, is proud to partner with some of the best surgeons in the region and provide them with quality technology.